These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 29299635

  • 1. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
    He X, Lai Q, Chen C, Li N, Sun F, Huang W, Zhang S, Yu Q, Yang P, Xiong F, Chen Z, Gong Q, Ren B, Weng J, Eizirik DL, Zhou Z, Wang CY.
    Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
    [Abstract] [Full Text] [Related]

  • 2. A post-translational balancing act: the good and the bad of SUMOylation in pancreatic islets.
    MacDonald PE.
    Diabetologia; 2018 Apr; 61(4):775-779. PubMed ID: 29330559
    [Abstract] [Full Text] [Related]

  • 3. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function.
    Baumel-Alterzon S, Katz LS, Lambertini L, Tse I, Heidery F, Garcia-Ocaña A, Scott DK.
    Diabetologia; 2024 Mar; 67(3):547-560. PubMed ID: 38206362
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
    Klug H, Xaver M, Chaugule VK, Koidl S, Mittler G, Klein F, Pichler A.
    Mol Cell; 2013 Jun 06; 50(5):625-36. PubMed ID: 23644018
    [Abstract] [Full Text] [Related]

  • 7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A.
    J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
    Gupta MK, McLendon PM, Gulick J, James J, Khalili K, Robbins J.
    Circ Res; 2016 Jun 10; 118(12):1894-905. PubMed ID: 27142163
    [Abstract] [Full Text] [Related]

  • 10. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
    López I, Chalatsi E, Ellenbroek SIJ, Andrieux A, Roux PF, Cerapio JP, Jouvion G, van Rheenen J, Seeler JS, Dejean A.
    Oncogene; 2020 Oct 10; 39(43):6692-6703. PubMed ID: 32948837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is Transthyretin a Regulator of Ubc9 SUMOylation?
    Wieczorek E, Kędracka-Krok S, Sołtys K, Jankowska U, Hołubowicz R, Seliga J, Ożyhar A.
    PLoS One; 2016 Oct 10; 11(8):e0160536. PubMed ID: 27501389
    [Abstract] [Full Text] [Related]

  • 14. Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function.
    Ding X, Wang A, Ma X, Demarque M, Jin W, Xin H, Dejean A, Dong C.
    Cell Rep; 2016 Jul 26; 16(4):1055-1066. PubMed ID: 27425617
    [Abstract] [Full Text] [Related]

  • 15. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J, Goodson ML, Hong Y, Sarge KD.
    J Biol Chem; 2008 Mar 21; 283(12):7464-9. PubMed ID: 18211895
    [Abstract] [Full Text] [Related]

  • 16. Protective Role of Nuclear Factor E2-Related Factor 2 against Acute Oxidative Stress-Induced Pancreatic β -Cell Damage.
    Fu J, Zheng H, Wang H, Yang B, Zhao R, Lu C, Liu Z, Hou Y, Xu Y, Zhang Q, Qu W, Pi J.
    Oxid Med Cell Longev; 2015 Mar 21; 2015():639191. PubMed ID: 25949772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.
    Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J.
    Circ Res; 2014 Sep 26; 115(8):721-9. PubMed ID: 25097219
    [Abstract] [Full Text] [Related]

  • 20. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S, Mealer RG, Sixt KM, Barrow RK, Usiello A, Snyder SH.
    J Biol Chem; 2010 Jul 02; 285(27):20428-32. PubMed ID: 20424159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.